Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.19.3.a.u2
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2019
Sep. 30, 2019
Current Assets    
Cash and cash equivalents $ 142.4 $ 399.0
Trade receivables, net 344.3 217.4
Receivables from long-term manufacturing contracts 205.9 181.1
Inventories, net 442.1 176.6
Prepaid expenses and other current assets 87.4 49.1
Other current assets 87.4 49.1
Total current assets 1,222.1 1,023.2
Property, plant, and equipment, net 398.1 140.3
Operating lease right-of-use assets 172.5 0.0
Intangible assets, net 1,317.7 454.9
Goodwill 1,256.9 578.0
Other long-term assets 53.4 32.2
Total Assets 4,420.7 2,228.6
Current Liabilities    
Trade accounts payable 349.0 236.2
Liabilities from long-term manufacturing contracts and advances 183.1 158.2
Current portion of long-term debt 42.1 0.0
Accrued compensation 86.2 73.2
Other current liabilities 219.4 121.7
Total current liabilities 879.8 589.3
Long-term debt 1,822.6 619.5
Accrued pension and postretirement healthcare 162.0 131.3
Operating lease liabilities 137.1 0.0
Deferred Income Tax Liabilities, Net 215.4 73.6
Other long-term liabilities 60.0 45.1
Total Liabilities 3,276.9 1,458.8
Commitments and contingencies (Note 15)
SHAREHOLDERS’ EQUITY    
Common stock, no par value (75.8 and 63.9 shares issued, 74.7 and 62.7 shares outstanding) 0.0 0.0
Additional paid-in capital 712.9 345.3
Retained earnings 586.5 599.5
Treasury stock (1.1 and 1.2 shares) (45.6) (50.1)
Accumulated other comprehensive loss (126.7) (140.6)
Hillenbrand Shareholders’ Equity 1,127.1 754.1
Noncontrolling interests 16.7 15.7
Total Shareholders’ Equity 1,143.8 769.8
Total Liabilities and Shareholders’ Equity $ 4,420.7 $ 2,228.6